Program et-a-glance is available for download here.

By clicking the tabs you can check detailed program day-by-day

17.30 – 18.30

Plenary Session 1

OPENING CEREMONY
Chairmen: Luc Zimmermann (the Netherlands), Silke Mader (Germany)

Extreme Everest: lessons learnt from high altitude
Daniel Martin (United Kingdom)

Learning from our mistakes
Martin Elliott(United Kingdom)

09.00 – 11.00

PARALLEL SESSION 1 NEURODEVELOPMENTAL OUTCOME AND CONGENITAL HEART DISEASE

Brain Health in Neonates with CHD: timing is everything
Steven Miller (Canada)

Neurodevelopmental outcome and congenital heart disease
Bea Latal (Switzerland)

Brain Health in Neonates with CHD: timing is everything
Petra Lemmers (the Netherlands)

Cognitive stability in children with congenital heart disease
Nadja Naef (Switzerland)

Congenital heart defects and academic performance in a nationwide cohort of 458,318 Danish children
Niels Bjerregård Matthiesen (Denmark)

Early postoperative amplitude-integrated electroencephalography: biomarker of new brain injury in neonates with congenital heart disease
Nathalie Claessens (Netherlands)

PARALLEL SESSION 2 RESUSCITATION

New techniques for optimising newborn resuscitation
Peter Davis (Australia)

Unravelling the physiology of haemodynamic transition at birth
Stuart Hooper (Australia)

Delayed cord clamping during resuscitation – a randomized trial
Ola Andersson (Sweden)

Sustained versus standard inflations during neonatal resuscitation to reduce mortality and improve respiratory outcomes: a systematic review and meta-analysis
Matteo Bruschettini (Sweden)

Comparison of laryngeal mask airway and endotracheal tube placement in neonates
Kari Roberts (United States)

nCPAP pressure at initiation: is higher pressure better?
Swapnil Bhisikar (India)

Bradyprem study: is heart rate the most vital of all vital signs during preterm resuscitation?
Vishal Kapadia (United States)

PARALLEL SESSION 3 PAIN REDUCTION – DOES A PARTNERSHIP WITH PARENTS REDUCE PAIN IN NEWBORNS?

The power of parents to reduce newborn pain
Marsha Campbell-Yeo (Canada)

Facilitators and barriers for parents’ involvement in pain management
Anna Axelin (Finland)

Working with parents to build better pain management for newborn infants
Mats Eriksson (Sweden)

A user centered design approach to evaluate a validated infant pain measure e- learning module
Bonnie Stevens (Canada)

PARALLEL SESSION 4 WHAT CAN WE LEARN FROM NEONATAL NETWORKS

Newborn: neonatal networks and surveillance of nosocomial infections
Dominique Haumont (Belgium)

The UK experience
Neena Modi (United Kingdom)

PARALLEL SESSION 5 NEONATAL NUTRITION UPDATES

Neuroimaging, a new tool for investigating the effects of early diet on cognitive and brain development
Elizabeth Isaacs (United Kingdom)

Improving neurological outcomes of preterm infant: update on the role of early nutrition
Sissel Moltu (Norway) 

Early parenteral use of a lipid emulsion containing fish oil results in improved longitudinal growth in extremely preterm infants – a randomized controlled trial
Svetlana Najm (Sweden)

Growth and body composition up to 4 months of age in preterm infants and term controls (PeaPod study)
Anna Chmielewska (Sweden)

Personalised prediction of weight changes in the first week of life
Severin Kasser (Switzerland)

Z-score differences based on cross-sectional growth charts do not reflect weight gain in preterm infants: an adjusted Z-score for longitudinal assessment of growth
Niels Rochow (Canada)

PARALLEL SESSION 6 WHO OWNS THE PLACENTAL BLOOD?

The case for the term infant
Ola Andersson (Sweden)

The case for the preterm infant
Heike Rabe (United Kingdom)

Harvesting placental blood: what is it for?
Anders Fasth (Sweden)

Placental Pathology and its Effect on Neonatal Haemodynamics
Etaoin Kent (Ireland)

Delayed cord clamping in preterm infants with suspected intrauterine growth restriction
Judith Mercer (United States)

The effects of delayed cord clamping on 12-months brain myelin content: a randomized controlled trial
Debra Erickson-Owens (United States)

The use of speckle tracking echocardiography to assess myocardial performance in monochorionic diamniotic twins with and without twin to twin transfusion syndrome
Colm Breatnach (Ireland)

11.00 – 11.30

COFFEE BREAK AND POSTER VIEWING

11.30 – 12.30

PLENARY SESSION 2 REGENERATIVE MEDICINE

Stem Cell Therapy for Neonatal Disorders; Prospects and Challenges
Won Soon Park (South Korea)

Stem cells for neonatal disorders
Paolo De Coppi (United Kingdom)

12.30 – 13.00

LUNCH BREAK

13.30 – 15:00

POSTER SESSION

15.00 – 17.00

PARALLEL SESSION 7 PRO – CON DEBATE

nCPAP vs HFNC
Haresh Kirpalani (United States) vs Peter Davis (Australia)

Newer strategies for surfactant delivery – who, when, where, why and how
Peter Dargaville (Australia)

Sudden versus pressure wean from nasal CPAP in very preterm infants: a multicenter randomized controlled trial
Christina Friis Jensen (Denmark)

Predictors and outcomes of continuous positive airway pressure and nasal high-flow treatment failure in preterm infants: a secondary analysis of a randomized trial
Brett Manley (Australia)

PARALLEL SESSION 8 MONITORING FOR INFANTS AT RISK

Cerebral autoregulation in asphyxiated neonates treated with hypothermia
Laura Dix (Netherlands)

Asynchrony and spectral eeg coherence in term neonates with intrauterine grow restriction
Beatriz Reyes Millán (Spain)

Early amplitude integrated electroencephalogram as a predictor of brain injury in newborns with very low birth weight: a cohort study
Rita C. Silveira (Brazil)

MRI-diagnosed white matter lesions in the brain of VLBW babies: risk factor analysis
Mariya Malova (Italy)

Perinatal associations with brain growth evaluated by sequential cranial ultrasonography in very preterm infants
Rocco Cuzzilla (Australia)

Bedside monitoring of cerebral metabolism in neonates at risk for hypoxic-ischemic encephalopathy
Mohamed El-Dib (United States)

Early neonatal EEG markers for dyslexia risk: a pilot study
Silvia Martini (United Kingdom)

PARALLEL SESSION 9 CONTROVERSIES IN NEONATAL NUTRITION

Preterm parenteral nutrition: Too much too soon or too little too late
Colin Morgan (United Kingdom)

Risks and benefits of insulin treatment in hyperglycaemic preterm neonates
Elsa Kermorvant (France)

Target fortification of breast milk with protein, carbohydrate and fat for preterm infants improves growth outcomes: a double­blind randomized controlled trial
Niels Rochow (Canada)

Targetting Glucose Control with Real Time Continuous Glucose Monitoring
Kathryn Beardsall (United Kingdom)

Bovine colostrum for preterm infants in the first days of life: a randomized controlled pilot trial
Sandra Meinich Juhl (Denmark)

Reducing variability in macronutrient intakes improves growth in preterm infants: target fortification of breast milk – a double-blind randomized controlled trial
Niels Rochow (Canada)

The effect of fish oil emulsions on lung function in preterm infants receiving parenteral nutrition
Virgilio Carnielli (Italy)

PARALLEL SESSION 10 CHALLENGES IN NEONATAL DRUG DEVELOPMENT

What you need to know from EMA PDCO
Mark Turner (United Kingdom)

The HIP trial story
Eugene Dempsey (Ireland)

Experiences from the NEO-CIRC trial
Heike Rabe (United Kingdom)

Adrin 1 methodology study: adverse drug reactions in neonates: what are the best ways to evaluate suspected adverse drug reactions in neonates?
Eve Roberts (United Kingdom)

Large differences in off-label and neonatal drug use still exist: time for consensus?
Robert Flint (Netherlands)

Urinary 17-α-hydroxy-progesterone as a potential marker of neonatal pain
Maire Brasseler (Germany)

Β3-adrenoceptor regulation of nitric oxide in the cord vascular system
Livia Provitera (Italy)

PARALLEL SESSION 11 WHAT SHOULD WE MONITOR?
GLOBAL HAEMODYNAMICS (SYSTEMIC BLOOD FLOW), END-ORGAN PERFUSION (REGIONAL BLOOD FLOW) OR THE MICROCIRCULATION (CAPILLARY BLOOD FLOW)?

It’s all about the heart
Willem de Boode (Netherlands)

It’s all about the brain
Gorm Greisen (Denmark)

Patent ductus arteriosus, cerebral haemodynamics and intraventricular haemorrhage in preterm neonates: a causal pathway study
Charalampos Kotidis (United Kingdom)

Electrical velocimetry in preterm infants: effect of time and gestational age
Lizelle Van Wyk (South Africa)

Molecular and genetic markers for prediction of resistance to inotropic therapy in newborns with arterial hypotension
Daria Kryuchko (Russia)

Glial fibrillary acidic protein plasma levels during congenital heart diseases surgery inversely correlate with vineland adaptive behavior scales communication score
Michele Salvagno (Italy)

PARALLEL SESSION 12 FAMILY CENTRED DEVELOPMENTAL SUPPORTIVE CARE – EVIDENCE OR PHILOSOPHY?

Family integrated care in the NICU – feasible and good for preterm infants?
Shoo Lee (Canada)

Developmental care – impact on the brain
Stéphane Sizozenko (Switzerland)

Influence of auditive NICU environment on the preterm baby
Pierre Kuhn (France)

17.00 – 17.30

COFFEE BREAK

17.30 – 18.30

PLENARY SESSION 3 BENGT ROBERTSON AWARD

Steroids and Surfactant and the Preterm Lung: Bench to Bedside and Back Again
Roberta and Phil Ballard (United States)

08.30 – 12.30

THEORETICAL COURSE NEONATOLOGIST PERFORMED ECOCARDIOGRAPHY (NPE)

Physics of Ultrasound and Artefact Recognition
Willem de Boode (Netherlands)

Routine Ultrasound Views
Afif El-Khuffash (Ireland)

Assessment of PDA
Patrick McNamara (Canada)

Assessment of PPHN
Shahab Noori (United States)

Assessment of Flow and Contractility
Nick Evans (Australia)

Advanced Ecocardiographic Technologies
Eirik Nestaas (Norway)
*Please note this course is not included in the congress fee, there is a additional registration for this course.

To register, click HERE.

08.30 – 10.30

PLENARY SESSION 4 YOUNG INVESTIGATOR PRIZE SESSION

10.30 – 11.00

COFFEE BREAK

11.00 – 12.30

PARALLEL SESSION 13 PHARMACOLOGY OF LUNG PROTECTION

Antenatal corticosteroids – current controversies
Lex Doyle (Australia)

Update on postnatal systemic and inhaled corticosteroids
Olivier Baud (France)

Update on respiratory stimulants and diuretics in BPD prevention
Christian Poets (Germany)

Using the combination of surfactant and budesonide the prevention of chronic lung disease in preterm infants with RDS
Olga Sapun (Russia)

Antenatal glucocorticoids attenuate changes by ventilation in expression of connective tissue growth factor (CTGF) in newborn rat lung
Miryan Mateos Polo (Spain)

Effect of commercially available surfactants on mortality and respiratory outcomes in preterm neonates with RDS: systematic reviews and meta-analysis
Lucia De Martino (France)

Secretory phospholipase a2 and inflammation profile in preterm babies with RDS receiving one or multiple surfactant doses
Shivani Shankar-Aguilera (France)

PARALLEL SESSION 14 TRANSITION TO ADULT LIFE

Cognition and attainment
Neil Marlow (United Kingdom)

Psychiatric outcomes
Chiara Nosarti (United Kingdom)

Cardiovascular health
Petteri Hovi (Finland)

Cognitive functioning in adolescents born moderately preterm at 32-26 weeks’ gestation: a Swedish regional population based case control study
Marie Adamsson (Sweden)

Inhibitory control at 20 months predicts VP/VLBW and term adults’ attention, IQ, and wealth at age 26 years
Julia Jaekel (United States)

Persistent mathematics learning difficulties from childhood to adolescence in very preterm children in mainstream school
Sarah Clayton (United Kingdom)

Cognitive trajectories from infancy to early adulthood following birth before 26 weeks of gestation
Louise Linsell (United Kingdom

PARALLEL SESSION 15 BRIDGING THE GAP BETWEEN NEONATAL PALLIATIVE CARE AND DEVELOPMENTAL CARE

TBA
Jacques Sizun (France)

TBA
Jos Latour (United Kingdom)

Retrospective analyses of parental counseling and decision making for extreme preterm birth in a tertiary Dutch perinatal center
Evelien de Booij (Netherlands)

Health care professionals’ and parents’ attitudes toward parental autonomy and the best interest of the extreme preterm infant: a national study in Switzerland
Manya Hendriks (Switzerland)  

Children’s outcomes at two-year follow-up after four years of structured multi-professional medical-ethical decision-making in a neonatal intensive care unit
Jeanine Sol (Netherlands)

The delivery of bad news: a one or 2-step approach? The case for Trisomy 21
Michael Schimmel (United States)

Neonatal organ donation: a potential new donor source for cell and organ transplantation
Ewa Henckel (Sweden)

PARALLEL SESSION 16 OUTCOME MEASURES IN CLINICAL STUDIES OF PRETERM BABIES

Composite outcomes in clinical NICU studies – pros and cons
Keith Barrington (Canada)

Measuring risk of postnatal endpoints
Olga Basso (Canada)

Rends in mortality and major morbidity of very preterm neonates in 10 national neonatal database: the international network for evaluation of outcomes (INEO) experience
Kei Lui (Australia)

Impact of major neonatal morbidities on the outcome at 6.5 years of children born extremely preterm: a Swedish national prospective study (express)
Aijaz Farooqi (Sweden)

Differential susceptibility effects of maternal sensitivity at age 6 on small for gestational age adults’ attention regulation and wealth at age 26
Tobey Nichols (United States)

Educational trajectories of school outcome after preterm birth
David Odd (United Kingdom)

In utero exposure to perfluoroalkyl and polyfluoroalkyl substances and attention and executive function in the offspring
Cathrine Carlsen Bach (Denmark)

PARALLEL SESSION 17 INFECTIOUS DISEASE

TBA
Sam Oddie (United Kingdom)

TBA
Christoph Buhrer (Germany)

Colonisation with gram-negative bacteria (GNB) in infants in a tertiary neonatal unit
Christina Kortsalioudaki (United Kingdom)

Antimicrobial activity of copper in reducing enviromental burden in a neonatal intensive care unit (NICU)
Evangelia Kouskouni (Greece)

The antisecretory factor in relation to preterm birth and inflammatory response
Anna Gustafsson (Sweden)

Can Endocan Predict Late Neonatal Sepsis?
Mehmet Buyuktiryaki (Turkey)

Comparison of the incidence, clinical features and outcomes of invasive candidiasis in children and neonates
Jen Fu Hsu (Taiwan)

12.30 – 13.30

LUNCH BREAK

13.30 – 14.30

POSTER SESSION

14.30 – 16.30

PARALLEL SESSION 18 NEONATAL ARDS: RECOGNISING THE EXISTENCE OF A SYNDROME ACROSS THE AGE

(endorsed by ESPR and ESPNIC)

Physiopathology of ARDS across the ages
Peter Rimensberger (Switzerland)

Biology of ARDS across the ages
Daniele De Luca (France)

The Montreux definition of neonatal ARDS
Martin K. Kneyber (the Netherlands)

The fate of neonates with ARDS: the second phase of neonatal ARDS project
Anton van Kaam (the Netherlands)

PARALLEL SESSION 19 OXYGENATION IN THE NEWBORN AND INFANT PERIOD

Embryonic and Fetal oxygenation and oxygen control
Satyan Lakshminrusimha (United States)

Oxygenation in the transition from fetal to newborn life
Max Vento (Spain)

Oxygen targets beyond the delivery room
Ola D Saugstad (Norway)

Oxygenation and growth in BPD
Robin Steinhorn (United States)

PARALLEL SESSION 20 VENTILATION SUPPORT 

Update on NIVM
Corrado Moretti (Italy)

Closed loop FiO2 controle
Nelson Claure (United States)

Automated oxygen control in the NICU  
Peter Dargaville (Australia)

Volume controlled or volume guarantee ventilation in preterm infants: a randomised controlled trial
Helen E. Chitty (United Kingdom)

Volume-targeted versus pressure-limited ventilation in neonates – a cochrane systematic review and meta-analysis updated 2017
Claus Klingenberg (Norway)

PARALLEL SESSION 21 DIGITAL PATIENT CARE – THE NEW DIMENSION ? 

Digital information – support or challenge? 
Silke Mader (Germany)

Web Camera Use in the Neonatal Intensive Care Unit: Impact on Nursing Workflow 
GIllian Kennedy (United Kingdom)

Using technology to continue Family Centred Care post Discharge
Alison McNulty (United Kingdom)

Development and implementation of an integrated family delivered neonatal care model including a parent support mobile app
Jayanta Banerjee (United Kingdom)

Tablet based parental feedback in neonatal transport
Prashanth Bhat (United Kingdom)

Development and evaluation of e learning education to support breastfeeding in NICU
Wendy Higman (United Kingdom) 

PARALLEL SESSION 22 NUTRITION OF THE ELBWI: IMPROVING NUTRITIONAL CARE

Electrolyte needs and balance in the EBLW, how to avoid disturbances 
Silvia Iacobelli (France)

How to integrate enteral intake when administering parenteral nutrition in ELBW infants?
Sissel Moltu (Norway)

Feeding strategies in neonates: the SIFT feeding trial
Jon Dorling (United Kingdom)

Patched skin bilirubin assay to monitor extremely preterm neonates undergoing phototherapy
Daniele De Luca (France)

The Norwegian preterm infant gut (PINGU) study: a metagenomic approach to gut microbiota composition and resistome in infants supplemented with probiotics
Eirin Esaiassen (Norway)

Assessment of enzymotherapy efficacy in case of lactase insufficiency in preterm infants
Vlasova Olena (Ukraine)

Detrimental mucosal effect of ibuprofen in the immature human intestine
Eric Tremblay (Canada)

PARALLEL SESSION 23 BIOMARKES IN TERM NEONATAL ENCEPHALOPATHY

Biomarkers in neonatal brak injury: can a systems biology approach lead us to the Holy Grail ?
Deidre Murray (Ireland)

Metabolic phenotyping to understand neonatal encephalopathy
Bobbi Fleiss (France)

Depression during pregnancy and dna methylation changes in cord blood
Anne-Cathrine Viuff (Denmark)

A novel cerebral ultrasound scoring system is associated with neurological outcome in neonates with hypoxic-ischemic encephalopathy
Kim Valerie Annink (Netherlands)

Placental histology findings as possible risk factors for MRI-detected brain lesions in VLBW infants
Alessandro Parodi (Italy)

MicroRNA Panel Validation in Hypoxic Ischemic Encephalopathy
Marc O’Sullivan (Ireland)

Phospholipid synthesis related biomarkers in plasma from newborns with hypoxic-ischemic encephalopathy
Julia Kuligowski (Spain) 

16.30 – 17.00

COFFEE BREAK

17.00 – 18.00

PLENARY SESSION 5 WILL BIG DATA CHANGE THE FUTURE?

Using Big Data for Cognitive Computing approaches to Personalised Medicine for Neonatal Care
Carolyn McGregor (Canada)

Big Data and Genetic Encephalopathic epilepsy
Mark Johnson (United Kingdom)

09.00 – 11.00

PARALLEL SESSION 24 STRESS AND DEVELOPMENT

Prenatal stress and its effects on the fetus and the child
Vivette Glover (United Kingdom)

Stress in health and disease; Stress, learning and plasticity
Marian Joels (Netherlands)

Differentiating the preterm phenotype: distinct profiles of development after late and moderately preterm birth
Samantha Johnson (United Kingdom)

Prenatal methadone exposure and neurodevelopmental and  neuroimaging outcomes: a systematic review
Vix Monnelly (United Kingdom)

Atypical brain development associated with prenatal methadone exposure
Vix Monnelly (United Kingdom)

Epigenetic differences in cord blood of newborns exposed to antidepressant medication during pregnancy – a study in the Aarhus birth cohort
Anne-Cathrine Viuff (Denmark)

Mental health in adolescents born at 23-25 weeks of gestation
Aijaz Farooqi (Sweden)

PARALLEL SESSION 25 Neuroprotection, EPO trial

TBA
Sandra Juul (United States)

Current Global Issues for Optimising Brain Protection of the Term Infant
Nikki Robertson (United Kingdom)

A mixed lipid emulsion –rich in docosahexaenoic acid (DHA)- and its effect on brain maturation in extremely low birth weight infants
Christoph Binder (Austria)

Thrombocytopenia is associated with severe retinopathy of prematurity clinically; in mice platelet transfusion suppresses retinopathy
Ann Hellström (Sweden)

Peripheral T cell depletion by fingolimod is associated with exacerbated hypoxic-ischemic brain injury in neonatal mice
Ivo Bendix (Germany)

Intranasally applied mesenchymal stem cells migrate to injured brain regions of newborn non-human primates
Nienke Wagenaar (Netherlands)

Maternal swimming during pregnancy protects the neonatal rat brain from hypoxic-ischemic injury
Stephane Sizonenko (Switzerland)

PARALLEL SESSION 26 NEW INSIGHTS IN FUTURE NEONATAL CARE

Tick-tock … pharmacotherapy and our body clock
Bert van der Horst (Netherlands)

Chronobiology in neonatology
Irwin Reiss (Germany)

Late cord clamping trial
William Tarnow-Mordi (Australia)

Pharmacokinetic and pharmacodynamic studies aiming for rational drug dosing in preterm neonates: the DINO study
Swantje Voeller (Netherlands)

Fentanyl for procedural pain in preterm newborn infants – a pharmacokinetic and pharmacodynamic study
Elisabeth Norman (Sweden)

Big data analyses for continuous evaluation of pharmacotherapy: a proof of principle with doxapram for preterm infants
Robert Bernard Flint (Netherlands)

Ibuprofen pharmacogenetic study in human milk SAMPLES
Virginie Rigourd (France)

PARALLEL SESSION 27 PHYSIOLOGY

PARALLEL SESSION 28 TRAINING GUIDELINES FOR NEONATOLOGIST PERFORMED ECOCARDIOGRAPHY (NPE) – AN INTERCONTINENTAL DEBATE

The North-American perspective
Patrick McNamara (Canada)

The Australian perspective
Nick Evans (Australia)

The United Kingdom perspective
Yogen Singh (United Kingdom)

The European perspective
Afif El-Khuffash (Ireland)

Incidental findings on routine targeted neonatal echocardiography performed in preterm infants less than 29 weeks gestation
Aisling Smith (Ireland)

Emerging quantitative echocardiographic markers of pulmonary vasculae disease and right ventricular dysfunction in extreme preterm infants with late pulmonary hypertension
Philip Levy (United States)

Novel methods to characterize right ventricular – pulmonary arterial coupling in extreme preterm infants with late onset pulmonary hypertension
Philip Levy (United States)

PARALLEL SESSION 29 MEASURING QUALITY OF CARE IN NEONATAL CARE

TBA
Boubou Hallberg (Sweden)

Nature and nurture – improving quality of care in a genetic cohort study
Wolfgang Göpel (Germany)

The implementation of the close collaboration with parents training program in 5 neonatal units – a qualitative study
Mirka Toivonen (Finland)

A pilot study assessing the effectiveness of a family-centered care intervention in preterm infants in China
Zhang Rong (China)

Core outcomes in neonatology: preliminary results
James William Harrison Webbe (United Kingdom)

Close collaboration with parents™ intervention prevents prolonged maternal postpartum depressive symptoms
Sari Ahlqvist-Björkroth (Finland)

Reducing medication errors on NICU – a quality improvement project
Duaa Adel Al Masri (United Arab Emirates)

11.00 – 11.30

COFFEE BREAK

11.30 – 12.30

PLENARY SESSION 6 IPRF PLENARY SESSION

Human Organoid a new way to study neurological disorders
Wieland Huttner (Germany)

From Population and Personalized Genomics to Personalized Medicine
Manolis Dermitzakis (Switzerland)

12.30 – 13.30

LUNCH BREAK

13.30 – 15.00

POSTER SESSION

15.00 – 17.00

PARALLEL SESSION 30 CONGENITAL BRAIN INFECTIONS

CMV cellular and molecular mechanisms
Pierre Szepetowski (France)

ZIKA congenital encephalopathies
Ferdinando Di Cunto (Italy)

Neonatal neuroimaging in symptomatic congenital CMV (cCMV) and its correlation with outcome: emphasis on white matter disease
Ana Alarcon (United Kingdom)

Postnatal MR-imaging and ADC measures in congential cytomegalovirus infection provide an added diagnostic value on cerebral ultrasound in characterizing white matter disease
Carine Martins (Canada

Hyperechogenicity of the lenticulostriate arteries: incidense and clinical impact in a tertiary NICU
Sylvia Gkantseva-Patsoura (Greece)

Systemic alterations in Hypoxia-inducible factor 1 expression and the NLRP3 inflammasome in post Neonatal Encephalopathy in school age children and response to melatonin in vitro   
Laura Russo (Ireland)

Systemic Inflammasome Activation in Neonatal Encephalopathy
Mary O’Dea (Ireland)

PARALLEL SESSION 31 STEROIDS IN NEONATOLOGY

Antenatal corticosteroids – current controversies
Lex Doyle (Australia)

Update on postnatal systemic and inhaled corticosteroids
Olivier Baud (France)

Update on respiratory stimulants and diuretics in BPD prevention
Christian Poets (Germany)

Cost-effectiveness of transcutaneous bilirubin (TcB) monitoring in a growing health economy
Mohammed Libab (United Arab Emirates)

Antenatal glucocorticoids attenuate changes by ventilation in expression of connective tissue growth factor (CTGF) in newborn rat lung
Miryan Mateos Polo (Spain)

Effect of commercially available surfactants on mortality and respiratory outcomes in preterm neonates with RDS: systematic reviews and meta-analysis         
Lucia De Martino (France)

Secretory phospholipase A2 and inflammation profile in preterm babies with RDS receiving one or multiple surfactant doses
Shivani Shankar-Aguilera (France)

PARALLEL SESSION 32 PERINATAL EPIDEMIOLOGY

Registry based perinatal epidemiology: the importance of sibling and generation data
Rolv Skjaerven (Norway)

Tests and prediction (biomarkers) of outcomes within perinatology and newborn medicine
TBA

Association between maternal body mass index in early pregnancy and incidence of cerebral palsy
Stefan Johansson (Sweden)

Prevalence of long-term neurodevelopmental impairment following extremely preterm birth in Europe: a systematic literature review
Sujata P. Sarda (United Kingdom)

Perinatal infections and cerebral palsy: are prolonged ruptures of membranes a risk factor in children born at term?
Maren Mynarek (Norway)

Congenital heart defects and the risk of spontaneous preterm birth: a nationwide study of 924,422 liveborn infants     
Niels Bjerregård Matthiesen (Denmark) 

The dose-effect relationship between gestational age and severe school difficulties – a Danish population-based register study
Rikke Wiingreen (Denmark)

PARALLEL SESSION 33 CHILDREN BORN PRETERM

RECAP, a EU Horizon2020 collaborative effort to harmonize existing and new follow-up data on preterm survivor children, adolsecents and adults
Dieter Wolke (United Kingdom)

Psychiatric outcomes following very preterm birth
Peter Anderson (Australia)

The brain and neuropsychiatric disorders in children born preterm
Ulrika Aden (Sweden)

PARALLEL SESSION 34 IUGR across specialities

Metabolic and oxidative phenotype of IUGR
Irene Cetin (Italy)

Cardiovascular assessment and outcome of the early IUGR
Tiziana Frusca (Italy)

The very preterm IUGR between Lung and Nutrition
Virgilio Carnielli (Italy)

The premature brain and the IUGR brain developmental trajectories
Petra Huppi (Switzerland)

IVH and IUGR: thoughts for improving neonatal care?
Luca Ramenghi (Italy)

PARALLEL SESSION 35 COINN GLOBAL PERSPECTIVE IN NEONATAL CARE

COINN’s leadership and partnerships to decrease mortality and morbidity and improve neonatal care – global perspective 
Karen New (Australia)

Using parent experiences for learning – exploring the use of parent narratives to inform education in neonatal care
Julia Petty (United Kingdom)

Not just neonatal survival – Developmental and Behavioural Surveillance for pre-school children born preterm
Margo Pritchard (Australia)

17.00 – 17.30

COFFEE BREAK

17.00 – 18.00

PLENARY SESSION 7 THE NEED OF MULTIDISCIPLINARY APPROACHES IN RESEARCH

The benefit of an equal partnership with parents in research
Mark Turner (United Kingdom)

How to involve and empower parents in research projects
Nicole Thiele (Germany)

The benefit of an active partnership with nurses in research
Agnes van den Hoogen (Netherlands)

09.00 – 11.00

PARALLEL SESSION 36 SENSORY OUTCOMES

Long term effects of neonatal pain
Suellen Walker (United Kingdom)

How harmful are anaesthetics
Jurgen C. de Graaff (Nethelands)

Neonatal pain, opioid and anaesthetic exposure; what remains in the human brain after the wheels of time?
Gerbrich van den Bosch (Netherlands)

Mode of delivery influences nociceptive sensitivity in newborn infants – the nocicop trial
Noemi Klarer (Switzerland)

Can differences in early functional connectivity in healthy newborns exposed to olfactory stimulation help us understand crying behaviour at 6 weeks of life?
Lorena Freitas (Switzerland)

The effect of morphine on early brain activity in extremely preterm infants: an observational multi-center study
Maria Luisa Tataranno (Netherlands)

Self-reported widespread pain in adults born early and late preterm
Kari Anne I. Evensen (Norway)

PARALLEL SESSION 37 AUTOPHAGY IN DEVELOPING BRAIN

Role of mitochondria and autophagy in perinatal brain damage
Henrik Hagberg (United Kingdom)

Autophagic cell death in perinatal brain injury: does it matter?
Anita Truttmann (Switzerland)

Blood based proteins that differentiate inflammation-sensitized hypoxia versus hypoxia alone within the 6h therapeutic window in a piglet model
Ingran Lingam (United Kingdom)

Autophagy inhibition protects in a preterm rat model of excitotoxic brain injury
Celine Descloux (Switzerland)

Interaction between acute therapeutic hypothermia and a delayed mesenchymal stem cell therapy in neonatal hypoxia-ischemia
Josephine Herz (Germany)

A comparison of the effects of short term whole body vibration, as experienced during neonatal ambulance transportation, on the developing brain
Lara Shipley (United Kingdom)

CEACAM1 expression in the cerebellum
Sebastian Prager (Germany)

PARALLEL SESSION 38 FETAL GROWTH – SIZE MATTERS

A database on fetal growth
Stephen Kennedy (United Kingdom)

Fetal lung imaging
Mieke Cannie (Belgium)

Can we assess the severity of neonatal respiratory distress by ultrasound? A comparison of three methods
Francesco Raimondi (Italy)

PCO2 levels and clinical and neurodevelopmental outcomes of extremely low birthweight infants
Ulrich H. Thome (Germany)

Alveolar surfactant composition in preterm infants with respiratory distress syndrome before exogenous surfactant administration:  effect of gestational age and inflammation
Enrica Bassi (Italy)

TGFβ signaling is critical for regulating a proximal differentiation program and lung branching morphogenesis through activating notch signalling
Po-Nien Tsao (Taiwan)

A randomised controlled trial of needle aspiration or chest drain insertion for pneumothorax in newborns (The NORD Trial), ISRCTN65161530
Madeleine C. Murphy (Ireland)

PARALLEL SESSION 39 PROGRAMMING BY EARLY NUTRITION IN PRETERM INFANTS: WHAT IS KNOW, WHAT IS HYPOTHESIZED?

Early nutrition and long term cardiovascular health
Umberto Simeoni (Switzerland)

Early nutrition of the preterm and metabolic diseases
Petteri Hovi (Finland)

Early-life protein intake in infants born extremely preterm is associated with higher blood pressure at school-age
Itay M Zamir (Sweden)

Prevalence of prediabetes and type 2 diabetes in young adults born with very low birth weight
Molly Talman (United States)

Transient postnatal overfeeding in mice leads to metabolic and hepatic disorders at adulthood
Catherine Yzydorczyk (Switzerland)

Effect of infant formula with protein content of 1.6g/100kcal fed between 3-12 months on body composition and adiposity at age 5 years
Ferdinand Haschke (United States)

Newborn bone health is affected by maternal bariatric surgery
Emma Malchau Carlsen (Denmark)

PARALLEL SESSION 40 NURSE SPECIALIST AND NURSE PRACTITIONER ROLES AND PRACTICES

New professional roles in neonatology, challenges and regulations
Odile Frauenfelder (the Netherlands)

Neonatal nursing, where we are and where we are going – the evolving role of NPs 
Karen Walker (Australia)

Case presentation: A neonate who suddenly collapses- deciphering the differential diagnoses 
Karen Walker (Australia)

Not just neonatal survival – the effects of cerebral palsy and long term morbidity & long term outcomes in terms of autism etc
Margo Pritchard (Australia)

PARALLEL SESSION 41 BRIDGING THE GAP BETWEEN HOSPITAL AND OUT-PATIENT CARE FOR HOSPITALISED NEWBORNS

TBA
George Damhuis (The Netherlands)

Graduating from the NICU and transition to the outpatient setting – what the primary care physician likes to know
Kai König (Switzerland)

Mother-infant closeness supports the breastfeeding of preterm infants at discharge
Simo Raiskila (Finland)

Supporting the peer supporter
Gill Thomson (United Kingdom)

Postpartum depression, bonding and coping strategies in mothers of newborns admitted to the neonatal unit
Roser Porta (Spain)

Two year neurodevelopmental follow up data: meeting metrics vs delivering quality assessments
Mira Parmar (United Kingdom) 

11.00 – 11.30

COFFEE BREAK

11.30 – 13.00

CLOSING SESSION PERSONALIZED MEDICINE

Epigenetics: an evolutionary perspective on chronic disease
Jonathan Wells (United Kingdom)

The impact of early life experiences on long term phenotype
Moshe Szyf (Canada)

+ Mon 30 Oct
+ Tue 31 Oct

17.30 – 18.30

Plenary Session 1

OPENING CEREMONY
Chairmen: Luc Zimmermann (the Netherlands), Silke Mader (Germany)

Extreme Everest: lessons learnt from high altitude
Daniel Martin (United Kingdom)

Learning from our mistakes
Martin Elliott(United Kingdom)

+ Wed 01 Nov

09.00 – 11.00

PARALLEL SESSION 1 NEURODEVELOPMENTAL OUTCOME AND CONGENITAL HEART DISEASE

Brain Health in Neonates with CHD: timing is everything
Steven Miller (Canada)

Neurodevelopmental outcome and congenital heart disease
Bea Latal (Switzerland)

Brain Health in Neonates with CHD: timing is everything
Petra Lemmers (the Netherlands)

Cognitive stability in children with congenital heart disease
Nadja Naef (Switzerland)

Congenital heart defects and academic performance in a nationwide cohort of 458,318 Danish children
Niels Bjerregård Matthiesen (Denmark)

Early postoperative amplitude-integrated electroencephalography: biomarker of new brain injury in neonates with congenital heart disease
Nathalie Claessens (Netherlands)

PARALLEL SESSION 2 RESUSCITATION

New techniques for optimising newborn resuscitation
Peter Davis (Australia)

Unravelling the physiology of haemodynamic transition at birth
Stuart Hooper (Australia)

Delayed cord clamping during resuscitation – a randomized trial
Ola Andersson (Sweden)

Sustained versus standard inflations during neonatal resuscitation to reduce mortality and improve respiratory outcomes: a systematic review and meta-analysis
Matteo Bruschettini (Sweden)

Comparison of laryngeal mask airway and endotracheal tube placement in neonates
Kari Roberts (United States)

nCPAP pressure at initiation: is higher pressure better?
Swapnil Bhisikar (India)

Bradyprem study: is heart rate the most vital of all vital signs during preterm resuscitation?
Vishal Kapadia (United States)

PARALLEL SESSION 3 PAIN REDUCTION – DOES A PARTNERSHIP WITH PARENTS REDUCE PAIN IN NEWBORNS?

The power of parents to reduce newborn pain
Marsha Campbell-Yeo (Canada)

Facilitators and barriers for parents’ involvement in pain management
Anna Axelin (Finland)

Working with parents to build better pain management for newborn infants
Mats Eriksson (Sweden)

A user centered design approach to evaluate a validated infant pain measure e- learning module
Bonnie Stevens (Canada)

PARALLEL SESSION 4 WHAT CAN WE LEARN FROM NEONATAL NETWORKS

Newborn: neonatal networks and surveillance of nosocomial infections
Dominique Haumont (Belgium)

The UK experience
Neena Modi (United Kingdom)

PARALLEL SESSION 5 NEONATAL NUTRITION UPDATES

Neuroimaging, a new tool for investigating the effects of early diet on cognitive and brain development
Elizabeth Isaacs (United Kingdom)

Improving neurological outcomes of preterm infant: update on the role of early nutrition
Sissel Moltu (Norway) 

Early parenteral use of a lipid emulsion containing fish oil results in improved longitudinal growth in extremely preterm infants – a randomized controlled trial
Svetlana Najm (Sweden)

Growth and body composition up to 4 months of age in preterm infants and term controls (PeaPod study)
Anna Chmielewska (Sweden)

Personalised prediction of weight changes in the first week of life
Severin Kasser (Switzerland)

Z-score differences based on cross-sectional growth charts do not reflect weight gain in preterm infants: an adjusted Z-score for longitudinal assessment of growth
Niels Rochow (Canada)

PARALLEL SESSION 6 WHO OWNS THE PLACENTAL BLOOD?

The case for the term infant
Ola Andersson (Sweden)

The case for the preterm infant
Heike Rabe (United Kingdom)

Harvesting placental blood: what is it for?
Anders Fasth (Sweden)

Placental Pathology and its Effect on Neonatal Haemodynamics
Etaoin Kent (Ireland)

Delayed cord clamping in preterm infants with suspected intrauterine growth restriction
Judith Mercer (United States)

The effects of delayed cord clamping on 12-months brain myelin content: a randomized controlled trial
Debra Erickson-Owens (United States)

The use of speckle tracking echocardiography to assess myocardial performance in monochorionic diamniotic twins with and without twin to twin transfusion syndrome
Colm Breatnach (Ireland)

11.00 – 11.30

COFFEE BREAK AND POSTER VIEWING

11.30 – 12.30

PLENARY SESSION 2 REGENERATIVE MEDICINE

Stem Cell Therapy for Neonatal Disorders; Prospects and Challenges
Won Soon Park (South Korea)

Stem cells for neonatal disorders
Paolo De Coppi (United Kingdom)

12.30 – 13.00

LUNCH BREAK

13.30 – 15:00

POSTER SESSION

15.00 – 17.00

PARALLEL SESSION 7 PRO – CON DEBATE

nCPAP vs HFNC
Haresh Kirpalani (United States) vs Peter Davis (Australia)

Newer strategies for surfactant delivery – who, when, where, why and how
Peter Dargaville (Australia)

Sudden versus pressure wean from nasal CPAP in very preterm infants: a multicenter randomized controlled trial
Christina Friis Jensen (Denmark)

Predictors and outcomes of continuous positive airway pressure and nasal high-flow treatment failure in preterm infants: a secondary analysis of a randomized trial
Brett Manley (Australia)

PARALLEL SESSION 8 MONITORING FOR INFANTS AT RISK

Cerebral autoregulation in asphyxiated neonates treated with hypothermia
Laura Dix (Netherlands)

Asynchrony and spectral eeg coherence in term neonates with intrauterine grow restriction
Beatriz Reyes Millán (Spain)

Early amplitude integrated electroencephalogram as a predictor of brain injury in newborns with very low birth weight: a cohort study
Rita C. Silveira (Brazil)

MRI-diagnosed white matter lesions in the brain of VLBW babies: risk factor analysis
Mariya Malova (Italy)

Perinatal associations with brain growth evaluated by sequential cranial ultrasonography in very preterm infants
Rocco Cuzzilla (Australia)

Bedside monitoring of cerebral metabolism in neonates at risk for hypoxic-ischemic encephalopathy
Mohamed El-Dib (United States)

Early neonatal EEG markers for dyslexia risk: a pilot study
Silvia Martini (United Kingdom)

PARALLEL SESSION 9 CONTROVERSIES IN NEONATAL NUTRITION

Preterm parenteral nutrition: Too much too soon or too little too late
Colin Morgan (United Kingdom)

Risks and benefits of insulin treatment in hyperglycaemic preterm neonates
Elsa Kermorvant (France)

Target fortification of breast milk with protein, carbohydrate and fat for preterm infants improves growth outcomes: a double­blind randomized controlled trial
Niels Rochow (Canada)

Targetting Glucose Control with Real Time Continuous Glucose Monitoring
Kathryn Beardsall (United Kingdom)

Bovine colostrum for preterm infants in the first days of life: a randomized controlled pilot trial
Sandra Meinich Juhl (Denmark)

Reducing variability in macronutrient intakes improves growth in preterm infants: target fortification of breast milk – a double-blind randomized controlled trial
Niels Rochow (Canada)

The effect of fish oil emulsions on lung function in preterm infants receiving parenteral nutrition
Virgilio Carnielli (Italy)

PARALLEL SESSION 10 CHALLENGES IN NEONATAL DRUG DEVELOPMENT

What you need to know from EMA PDCO
Mark Turner (United Kingdom)

The HIP trial story
Eugene Dempsey (Ireland)

Experiences from the NEO-CIRC trial
Heike Rabe (United Kingdom)

Adrin 1 methodology study: adverse drug reactions in neonates: what are the best ways to evaluate suspected adverse drug reactions in neonates?
Eve Roberts (United Kingdom)

Large differences in off-label and neonatal drug use still exist: time for consensus?
Robert Flint (Netherlands)

Urinary 17-α-hydroxy-progesterone as a potential marker of neonatal pain
Maire Brasseler (Germany)

Β3-adrenoceptor regulation of nitric oxide in the cord vascular system
Livia Provitera (Italy)

PARALLEL SESSION 11 WHAT SHOULD WE MONITOR?
GLOBAL HAEMODYNAMICS (SYSTEMIC BLOOD FLOW), END-ORGAN PERFUSION (REGIONAL BLOOD FLOW) OR THE MICROCIRCULATION (CAPILLARY BLOOD FLOW)?

It’s all about the heart
Willem de Boode (Netherlands)

It’s all about the brain
Gorm Greisen (Denmark)

Patent ductus arteriosus, cerebral haemodynamics and intraventricular haemorrhage in preterm neonates: a causal pathway study
Charalampos Kotidis (United Kingdom)

Electrical velocimetry in preterm infants: effect of time and gestational age
Lizelle Van Wyk (South Africa)

Molecular and genetic markers for prediction of resistance to inotropic therapy in newborns with arterial hypotension
Daria Kryuchko (Russia)

Glial fibrillary acidic protein plasma levels during congenital heart diseases surgery inversely correlate with vineland adaptive behavior scales communication score
Michele Salvagno (Italy)

PARALLEL SESSION 12 FAMILY CENTRED DEVELOPMENTAL SUPPORTIVE CARE – EVIDENCE OR PHILOSOPHY?

Family integrated care in the NICU – feasible and good for preterm infants?
Shoo Lee (Canada)

Developmental care – impact on the brain
Stéphane Sizozenko (Switzerland)

Influence of auditive NICU environment on the preterm baby
Pierre Kuhn (France)

17.00 – 17.30

COFFEE BREAK

17.30 – 18.30

PLENARY SESSION 3 BENGT ROBERTSON AWARD

Steroids and Surfactant and the Preterm Lung: Bench to Bedside and Back Again
Roberta and Phil Ballard (United States)

+ Thu 02 Nov

08.30 – 12.30

THEORETICAL COURSE NEONATOLOGIST PERFORMED ECOCARDIOGRAPHY (NPE)

Physics of Ultrasound and Artefact Recognition
Willem de Boode (Netherlands)

Routine Ultrasound Views
Afif El-Khuffash (Ireland)

Assessment of PDA
Patrick McNamara (Canada)

Assessment of PPHN
Shahab Noori (United States)

Assessment of Flow and Contractility
Nick Evans (Australia)

Advanced Ecocardiographic Technologies
Eirik Nestaas (Norway)
*Please note this course is not included in the congress fee, there is a additional registration for this course.

To register, click HERE.

08.30 – 10.30

PLENARY SESSION 4 YOUNG INVESTIGATOR PRIZE SESSION

10.30 – 11.00

COFFEE BREAK

11.00 – 12.30

PARALLEL SESSION 13 PHARMACOLOGY OF LUNG PROTECTION

Antenatal corticosteroids – current controversies
Lex Doyle (Australia)

Update on postnatal systemic and inhaled corticosteroids
Olivier Baud (France)

Update on respiratory stimulants and diuretics in BPD prevention
Christian Poets (Germany)

Using the combination of surfactant and budesonide the prevention of chronic lung disease in preterm infants with RDS
Olga Sapun (Russia)

Antenatal glucocorticoids attenuate changes by ventilation in expression of connective tissue growth factor (CTGF) in newborn rat lung
Miryan Mateos Polo (Spain)

Effect of commercially available surfactants on mortality and respiratory outcomes in preterm neonates with RDS: systematic reviews and meta-analysis
Lucia De Martino (France)

Secretory phospholipase a2 and inflammation profile in preterm babies with RDS receiving one or multiple surfactant doses
Shivani Shankar-Aguilera (France)

PARALLEL SESSION 14 TRANSITION TO ADULT LIFE

Cognition and attainment
Neil Marlow (United Kingdom)

Psychiatric outcomes
Chiara Nosarti (United Kingdom)

Cardiovascular health
Petteri Hovi (Finland)

Cognitive functioning in adolescents born moderately preterm at 32-26 weeks’ gestation: a Swedish regional population based case control study
Marie Adamsson (Sweden)

Inhibitory control at 20 months predicts VP/VLBW and term adults’ attention, IQ, and wealth at age 26 years
Julia Jaekel (United States)

Persistent mathematics learning difficulties from childhood to adolescence in very preterm children in mainstream school
Sarah Clayton (United Kingdom)

Cognitive trajectories from infancy to early adulthood following birth before 26 weeks of gestation
Louise Linsell (United Kingdom

PARALLEL SESSION 15 BRIDGING THE GAP BETWEEN NEONATAL PALLIATIVE CARE AND DEVELOPMENTAL CARE

TBA
Jacques Sizun (France)

TBA
Jos Latour (United Kingdom)

Retrospective analyses of parental counseling and decision making for extreme preterm birth in a tertiary Dutch perinatal center
Evelien de Booij (Netherlands)

Health care professionals’ and parents’ attitudes toward parental autonomy and the best interest of the extreme preterm infant: a national study in Switzerland
Manya Hendriks (Switzerland)  

Children’s outcomes at two-year follow-up after four years of structured multi-professional medical-ethical decision-making in a neonatal intensive care unit
Jeanine Sol (Netherlands)

The delivery of bad news: a one or 2-step approach? The case for Trisomy 21
Michael Schimmel (United States)

Neonatal organ donation: a potential new donor source for cell and organ transplantation
Ewa Henckel (Sweden)

PARALLEL SESSION 16 OUTCOME MEASURES IN CLINICAL STUDIES OF PRETERM BABIES

Composite outcomes in clinical NICU studies – pros and cons
Keith Barrington (Canada)

Measuring risk of postnatal endpoints
Olga Basso (Canada)

Rends in mortality and major morbidity of very preterm neonates in 10 national neonatal database: the international network for evaluation of outcomes (INEO) experience
Kei Lui (Australia)

Impact of major neonatal morbidities on the outcome at 6.5 years of children born extremely preterm: a Swedish national prospective study (express)
Aijaz Farooqi (Sweden)

Differential susceptibility effects of maternal sensitivity at age 6 on small for gestational age adults’ attention regulation and wealth at age 26
Tobey Nichols (United States)

Educational trajectories of school outcome after preterm birth
David Odd (United Kingdom)

In utero exposure to perfluoroalkyl and polyfluoroalkyl substances and attention and executive function in the offspring
Cathrine Carlsen Bach (Denmark)

PARALLEL SESSION 17 INFECTIOUS DISEASE

TBA
Sam Oddie (United Kingdom)

TBA
Christoph Buhrer (Germany)

Colonisation with gram-negative bacteria (GNB) in infants in a tertiary neonatal unit
Christina Kortsalioudaki (United Kingdom)

Antimicrobial activity of copper in reducing enviromental burden in a neonatal intensive care unit (NICU)
Evangelia Kouskouni (Greece)

The antisecretory factor in relation to preterm birth and inflammatory response
Anna Gustafsson (Sweden)

Can Endocan Predict Late Neonatal Sepsis?
Mehmet Buyuktiryaki (Turkey)

Comparison of the incidence, clinical features and outcomes of invasive candidiasis in children and neonates
Jen Fu Hsu (Taiwan)

12.30 – 13.30

LUNCH BREAK

13.30 – 14.30

POSTER SESSION

14.30 – 16.30

PARALLEL SESSION 18 NEONATAL ARDS: RECOGNISING THE EXISTENCE OF A SYNDROME ACROSS THE AGE

(endorsed by ESPR and ESPNIC)

Physiopathology of ARDS across the ages
Peter Rimensberger (Switzerland)

Biology of ARDS across the ages
Daniele De Luca (France)

The Montreux definition of neonatal ARDS
Martin K. Kneyber (the Netherlands)

The fate of neonates with ARDS: the second phase of neonatal ARDS project
Anton van Kaam (the Netherlands)

PARALLEL SESSION 19 OXYGENATION IN THE NEWBORN AND INFANT PERIOD

Embryonic and Fetal oxygenation and oxygen control
Satyan Lakshminrusimha (United States)

Oxygenation in the transition from fetal to newborn life
Max Vento (Spain)

Oxygen targets beyond the delivery room
Ola D Saugstad (Norway)

Oxygenation and growth in BPD
Robin Steinhorn (United States)

PARALLEL SESSION 20 VENTILATION SUPPORT 

Update on NIVM
Corrado Moretti (Italy)

Closed loop FiO2 controle
Nelson Claure (United States)

Automated oxygen control in the NICU  
Peter Dargaville (Australia)

Volume controlled or volume guarantee ventilation in preterm infants: a randomised controlled trial
Helen E. Chitty (United Kingdom)

Volume-targeted versus pressure-limited ventilation in neonates – a cochrane systematic review and meta-analysis updated 2017
Claus Klingenberg (Norway)

PARALLEL SESSION 21 DIGITAL PATIENT CARE – THE NEW DIMENSION ? 

Digital information – support or challenge? 
Silke Mader (Germany)

Web Camera Use in the Neonatal Intensive Care Unit: Impact on Nursing Workflow 
GIllian Kennedy (United Kingdom)

Using technology to continue Family Centred Care post Discharge
Alison McNulty (United Kingdom)

Development and implementation of an integrated family delivered neonatal care model including a parent support mobile app
Jayanta Banerjee (United Kingdom)

Tablet based parental feedback in neonatal transport
Prashanth Bhat (United Kingdom)

Development and evaluation of e learning education to support breastfeeding in NICU
Wendy Higman (United Kingdom) 

PARALLEL SESSION 22 NUTRITION OF THE ELBWI: IMPROVING NUTRITIONAL CARE

Electrolyte needs and balance in the EBLW, how to avoid disturbances 
Silvia Iacobelli (France)

How to integrate enteral intake when administering parenteral nutrition in ELBW infants?
Sissel Moltu (Norway)

Feeding strategies in neonates: the SIFT feeding trial
Jon Dorling (United Kingdom)

Patched skin bilirubin assay to monitor extremely preterm neonates undergoing phototherapy
Daniele De Luca (France)

The Norwegian preterm infant gut (PINGU) study: a metagenomic approach to gut microbiota composition and resistome in infants supplemented with probiotics
Eirin Esaiassen (Norway)

Assessment of enzymotherapy efficacy in case of lactase insufficiency in preterm infants
Vlasova Olena (Ukraine)

Detrimental mucosal effect of ibuprofen in the immature human intestine
Eric Tremblay (Canada)

PARALLEL SESSION 23 BIOMARKES IN TERM NEONATAL ENCEPHALOPATHY

Biomarkers in neonatal brak injury: can a systems biology approach lead us to the Holy Grail ?
Deidre Murray (Ireland)

Metabolic phenotyping to understand neonatal encephalopathy
Bobbi Fleiss (France)

Depression during pregnancy and dna methylation changes in cord blood
Anne-Cathrine Viuff (Denmark)

A novel cerebral ultrasound scoring system is associated with neurological outcome in neonates with hypoxic-ischemic encephalopathy
Kim Valerie Annink (Netherlands)

Placental histology findings as possible risk factors for MRI-detected brain lesions in VLBW infants
Alessandro Parodi (Italy)

MicroRNA Panel Validation in Hypoxic Ischemic Encephalopathy
Marc O’Sullivan (Ireland)

Phospholipid synthesis related biomarkers in plasma from newborns with hypoxic-ischemic encephalopathy
Julia Kuligowski (Spain) 

16.30 – 17.00

COFFEE BREAK

17.00 – 18.00

PLENARY SESSION 5 WILL BIG DATA CHANGE THE FUTURE?

Using Big Data for Cognitive Computing approaches to Personalised Medicine for Neonatal Care
Carolyn McGregor (Canada)

Big Data and Genetic Encephalopathic epilepsy
Mark Johnson (United Kingdom)

+ Fri 03 Nov

09.00 – 11.00

PARALLEL SESSION 24 STRESS AND DEVELOPMENT

Prenatal stress and its effects on the fetus and the child
Vivette Glover (United Kingdom)

Stress in health and disease; Stress, learning and plasticity
Marian Joels (Netherlands)

Differentiating the preterm phenotype: distinct profiles of development after late and moderately preterm birth
Samantha Johnson (United Kingdom)

Prenatal methadone exposure and neurodevelopmental and  neuroimaging outcomes: a systematic review
Vix Monnelly (United Kingdom)

Atypical brain development associated with prenatal methadone exposure
Vix Monnelly (United Kingdom)

Epigenetic differences in cord blood of newborns exposed to antidepressant medication during pregnancy – a study in the Aarhus birth cohort
Anne-Cathrine Viuff (Denmark)

Mental health in adolescents born at 23-25 weeks of gestation
Aijaz Farooqi (Sweden)

PARALLEL SESSION 25 Neuroprotection, EPO trial

TBA
Sandra Juul (United States)

Current Global Issues for Optimising Brain Protection of the Term Infant
Nikki Robertson (United Kingdom)

A mixed lipid emulsion –rich in docosahexaenoic acid (DHA)- and its effect on brain maturation in extremely low birth weight infants
Christoph Binder (Austria)

Thrombocytopenia is associated with severe retinopathy of prematurity clinically; in mice platelet transfusion suppresses retinopathy
Ann Hellström (Sweden)

Peripheral T cell depletion by fingolimod is associated with exacerbated hypoxic-ischemic brain injury in neonatal mice
Ivo Bendix (Germany)

Intranasally applied mesenchymal stem cells migrate to injured brain regions of newborn non-human primates
Nienke Wagenaar (Netherlands)

Maternal swimming during pregnancy protects the neonatal rat brain from hypoxic-ischemic injury
Stephane Sizonenko (Switzerland)

PARALLEL SESSION 26 NEW INSIGHTS IN FUTURE NEONATAL CARE

Tick-tock … pharmacotherapy and our body clock
Bert van der Horst (Netherlands)

Chronobiology in neonatology
Irwin Reiss (Germany)

Late cord clamping trial
William Tarnow-Mordi (Australia)

Pharmacokinetic and pharmacodynamic studies aiming for rational drug dosing in preterm neonates: the DINO study
Swantje Voeller (Netherlands)

Fentanyl for procedural pain in preterm newborn infants – a pharmacokinetic and pharmacodynamic study
Elisabeth Norman (Sweden)

Big data analyses for continuous evaluation of pharmacotherapy: a proof of principle with doxapram for preterm infants
Robert Bernard Flint (Netherlands)

Ibuprofen pharmacogenetic study in human milk SAMPLES
Virginie Rigourd (France)

PARALLEL SESSION 27 PHYSIOLOGY

PARALLEL SESSION 28 TRAINING GUIDELINES FOR NEONATOLOGIST PERFORMED ECOCARDIOGRAPHY (NPE) – AN INTERCONTINENTAL DEBATE

The North-American perspective
Patrick McNamara (Canada)

The Australian perspective
Nick Evans (Australia)

The United Kingdom perspective
Yogen Singh (United Kingdom)

The European perspective
Afif El-Khuffash (Ireland)

Incidental findings on routine targeted neonatal echocardiography performed in preterm infants less than 29 weeks gestation
Aisling Smith (Ireland)

Emerging quantitative echocardiographic markers of pulmonary vasculae disease and right ventricular dysfunction in extreme preterm infants with late pulmonary hypertension
Philip Levy (United States)

Novel methods to characterize right ventricular – pulmonary arterial coupling in extreme preterm infants with late onset pulmonary hypertension
Philip Levy (United States)

PARALLEL SESSION 29 MEASURING QUALITY OF CARE IN NEONATAL CARE

TBA
Boubou Hallberg (Sweden)

Nature and nurture – improving quality of care in a genetic cohort study
Wolfgang Göpel (Germany)

The implementation of the close collaboration with parents training program in 5 neonatal units – a qualitative study
Mirka Toivonen (Finland)

A pilot study assessing the effectiveness of a family-centered care intervention in preterm infants in China
Zhang Rong (China)

Core outcomes in neonatology: preliminary results
James William Harrison Webbe (United Kingdom)

Close collaboration with parents™ intervention prevents prolonged maternal postpartum depressive symptoms
Sari Ahlqvist-Björkroth (Finland)

Reducing medication errors on NICU – a quality improvement project
Duaa Adel Al Masri (United Arab Emirates)

11.00 – 11.30

COFFEE BREAK

11.30 – 12.30

PLENARY SESSION 6 IPRF PLENARY SESSION

Human Organoid a new way to study neurological disorders
Wieland Huttner (Germany)

From Population and Personalized Genomics to Personalized Medicine
Manolis Dermitzakis (Switzerland)

12.30 – 13.30

LUNCH BREAK

13.30 – 15.00

POSTER SESSION

15.00 – 17.00

PARALLEL SESSION 30 CONGENITAL BRAIN INFECTIONS

CMV cellular and molecular mechanisms
Pierre Szepetowski (France)

ZIKA congenital encephalopathies
Ferdinando Di Cunto (Italy)

Neonatal neuroimaging in symptomatic congenital CMV (cCMV) and its correlation with outcome: emphasis on white matter disease
Ana Alarcon (United Kingdom)

Postnatal MR-imaging and ADC measures in congential cytomegalovirus infection provide an added diagnostic value on cerebral ultrasound in characterizing white matter disease
Carine Martins (Canada

Hyperechogenicity of the lenticulostriate arteries: incidense and clinical impact in a tertiary NICU
Sylvia Gkantseva-Patsoura (Greece)

Systemic alterations in Hypoxia-inducible factor 1 expression and the NLRP3 inflammasome in post Neonatal Encephalopathy in school age children and response to melatonin in vitro   
Laura Russo (Ireland)

Systemic Inflammasome Activation in Neonatal Encephalopathy
Mary O’Dea (Ireland)

PARALLEL SESSION 31 STEROIDS IN NEONATOLOGY

Antenatal corticosteroids – current controversies
Lex Doyle (Australia)

Update on postnatal systemic and inhaled corticosteroids
Olivier Baud (France)

Update on respiratory stimulants and diuretics in BPD prevention
Christian Poets (Germany)

Cost-effectiveness of transcutaneous bilirubin (TcB) monitoring in a growing health economy
Mohammed Libab (United Arab Emirates)

Antenatal glucocorticoids attenuate changes by ventilation in expression of connective tissue growth factor (CTGF) in newborn rat lung
Miryan Mateos Polo (Spain)

Effect of commercially available surfactants on mortality and respiratory outcomes in preterm neonates with RDS: systematic reviews and meta-analysis         
Lucia De Martino (France)

Secretory phospholipase A2 and inflammation profile in preterm babies with RDS receiving one or multiple surfactant doses
Shivani Shankar-Aguilera (France)

PARALLEL SESSION 32 PERINATAL EPIDEMIOLOGY

Registry based perinatal epidemiology: the importance of sibling and generation data
Rolv Skjaerven (Norway)

Tests and prediction (biomarkers) of outcomes within perinatology and newborn medicine
TBA

Association between maternal body mass index in early pregnancy and incidence of cerebral palsy
Stefan Johansson (Sweden)

Prevalence of long-term neurodevelopmental impairment following extremely preterm birth in Europe: a systematic literature review
Sujata P. Sarda (United Kingdom)

Perinatal infections and cerebral palsy: are prolonged ruptures of membranes a risk factor in children born at term?
Maren Mynarek (Norway)

Congenital heart defects and the risk of spontaneous preterm birth: a nationwide study of 924,422 liveborn infants     
Niels Bjerregård Matthiesen (Denmark) 

The dose-effect relationship between gestational age and severe school difficulties – a Danish population-based register study
Rikke Wiingreen (Denmark)

PARALLEL SESSION 33 CHILDREN BORN PRETERM

RECAP, a EU Horizon2020 collaborative effort to harmonize existing and new follow-up data on preterm survivor children, adolsecents and adults
Dieter Wolke (United Kingdom)

Psychiatric outcomes following very preterm birth
Peter Anderson (Australia)

The brain and neuropsychiatric disorders in children born preterm
Ulrika Aden (Sweden)

PARALLEL SESSION 34 IUGR across specialities

Metabolic and oxidative phenotype of IUGR
Irene Cetin (Italy)

Cardiovascular assessment and outcome of the early IUGR
Tiziana Frusca (Italy)

The very preterm IUGR between Lung and Nutrition
Virgilio Carnielli (Italy)

The premature brain and the IUGR brain developmental trajectories
Petra Huppi (Switzerland)

IVH and IUGR: thoughts for improving neonatal care?
Luca Ramenghi (Italy)

PARALLEL SESSION 35 COINN GLOBAL PERSPECTIVE IN NEONATAL CARE

COINN’s leadership and partnerships to decrease mortality and morbidity and improve neonatal care – global perspective 
Karen New (Australia)

Using parent experiences for learning – exploring the use of parent narratives to inform education in neonatal care
Julia Petty (United Kingdom)

Not just neonatal survival – Developmental and Behavioural Surveillance for pre-school children born preterm
Margo Pritchard (Australia)

17.00 – 17.30

COFFEE BREAK

17.00 – 18.00

PLENARY SESSION 7 THE NEED OF MULTIDISCIPLINARY APPROACHES IN RESEARCH

The benefit of an equal partnership with parents in research
Mark Turner (United Kingdom)

How to involve and empower parents in research projects
Nicole Thiele (Germany)

The benefit of an active partnership with nurses in research
Agnes van den Hoogen (Netherlands)

+ Sat 04 Nov

09.00 – 11.00

PARALLEL SESSION 36 SENSORY OUTCOMES

Long term effects of neonatal pain
Suellen Walker (United Kingdom)

How harmful are anaesthetics
Jurgen C. de Graaff (Nethelands)

Neonatal pain, opioid and anaesthetic exposure; what remains in the human brain after the wheels of time?
Gerbrich van den Bosch (Netherlands)

Mode of delivery influences nociceptive sensitivity in newborn infants – the nocicop trial
Noemi Klarer (Switzerland)

Can differences in early functional connectivity in healthy newborns exposed to olfactory stimulation help us understand crying behaviour at 6 weeks of life?
Lorena Freitas (Switzerland)

The effect of morphine on early brain activity in extremely preterm infants: an observational multi-center study
Maria Luisa Tataranno (Netherlands)

Self-reported widespread pain in adults born early and late preterm
Kari Anne I. Evensen (Norway)

PARALLEL SESSION 37 AUTOPHAGY IN DEVELOPING BRAIN

Role of mitochondria and autophagy in perinatal brain damage
Henrik Hagberg (United Kingdom)

Autophagic cell death in perinatal brain injury: does it matter?
Anita Truttmann (Switzerland)

Blood based proteins that differentiate inflammation-sensitized hypoxia versus hypoxia alone within the 6h therapeutic window in a piglet model
Ingran Lingam (United Kingdom)

Autophagy inhibition protects in a preterm rat model of excitotoxic brain injury
Celine Descloux (Switzerland)

Interaction between acute therapeutic hypothermia and a delayed mesenchymal stem cell therapy in neonatal hypoxia-ischemia
Josephine Herz (Germany)

A comparison of the effects of short term whole body vibration, as experienced during neonatal ambulance transportation, on the developing brain
Lara Shipley (United Kingdom)

CEACAM1 expression in the cerebellum
Sebastian Prager (Germany)

PARALLEL SESSION 38 FETAL GROWTH – SIZE MATTERS

A database on fetal growth
Stephen Kennedy (United Kingdom)

Fetal lung imaging
Mieke Cannie (Belgium)

Can we assess the severity of neonatal respiratory distress by ultrasound? A comparison of three methods
Francesco Raimondi (Italy)

PCO2 levels and clinical and neurodevelopmental outcomes of extremely low birthweight infants
Ulrich H. Thome (Germany)

Alveolar surfactant composition in preterm infants with respiratory distress syndrome before exogenous surfactant administration:  effect of gestational age and inflammation
Enrica Bassi (Italy)

TGFβ signaling is critical for regulating a proximal differentiation program and lung branching morphogenesis through activating notch signalling
Po-Nien Tsao (Taiwan)

A randomised controlled trial of needle aspiration or chest drain insertion for pneumothorax in newborns (The NORD Trial), ISRCTN65161530
Madeleine C. Murphy (Ireland)

PARALLEL SESSION 39 PROGRAMMING BY EARLY NUTRITION IN PRETERM INFANTS: WHAT IS KNOW, WHAT IS HYPOTHESIZED?

Early nutrition and long term cardiovascular health
Umberto Simeoni (Switzerland)

Early nutrition of the preterm and metabolic diseases
Petteri Hovi (Finland)

Early-life protein intake in infants born extremely preterm is associated with higher blood pressure at school-age
Itay M Zamir (Sweden)

Prevalence of prediabetes and type 2 diabetes in young adults born with very low birth weight
Molly Talman (United States)

Transient postnatal overfeeding in mice leads to metabolic and hepatic disorders at adulthood
Catherine Yzydorczyk (Switzerland)

Effect of infant formula with protein content of 1.6g/100kcal fed between 3-12 months on body composition and adiposity at age 5 years
Ferdinand Haschke (United States)

Newborn bone health is affected by maternal bariatric surgery
Emma Malchau Carlsen (Denmark)

PARALLEL SESSION 40 NURSE SPECIALIST AND NURSE PRACTITIONER ROLES AND PRACTICES

New professional roles in neonatology, challenges and regulations
Odile Frauenfelder (the Netherlands)

Neonatal nursing, where we are and where we are going – the evolving role of NPs 
Karen Walker (Australia)

Case presentation: A neonate who suddenly collapses- deciphering the differential diagnoses 
Karen Walker (Australia)

Not just neonatal survival – the effects of cerebral palsy and long term morbidity & long term outcomes in terms of autism etc
Margo Pritchard (Australia)

PARALLEL SESSION 41 BRIDGING THE GAP BETWEEN HOSPITAL AND OUT-PATIENT CARE FOR HOSPITALISED NEWBORNS

TBA
George Damhuis (The Netherlands)

Graduating from the NICU and transition to the outpatient setting – what the primary care physician likes to know
Kai König (Switzerland)

Mother-infant closeness supports the breastfeeding of preterm infants at discharge
Simo Raiskila (Finland)

Supporting the peer supporter
Gill Thomson (United Kingdom)

Postpartum depression, bonding and coping strategies in mothers of newborns admitted to the neonatal unit
Roser Porta (Spain)

Two year neurodevelopmental follow up data: meeting metrics vs delivering quality assessments
Mira Parmar (United Kingdom) 

11.00 – 11.30

COFFEE BREAK

11.30 – 13.00

CLOSING SESSION PERSONALIZED MEDICINE

Epigenetics: an evolutionary perspective on chronic disease
Jonathan Wells (United Kingdom)

The impact of early life experiences on long term phenotype
Moshe Szyf (Canada)